TABLE 3.

Multivariable logistic regression analysis of factors associated with BZD and Z-Hypnotics consumption in patients with long COVID-19.

	Male	Female	Both gender
	AOR (95% CI)	AOR (95% CI)	AOR (95% CI)
Age group
>55 years	1	1	1
40–55 years	1.06 (0.30–3.80)	1.36 (0.70–2.62)	1.22 (0.69–2.16)
<40 years	5.52 (1.08–28.27)	0.73 (0.31–1.72)	1.20 (0.57–2.54)
Smoking habit in the past 12 months
Non-smoker	1	1	1
Smoker	ns	2.76 (1.16–6.52)	2.34 (1.05–5.24)
Ex-smoker	ns	1.80 (1.05–3.06)	1.38 (0.86–2.2)
Number of post-COVID symptoms
	ns	1.36 (1.23–1.51)	1.26 (1.16–1.37)
Number of medications consumed other than BZD and Z-drugs in the past 30 days
Female	ns		1.32 (0.75–2.31)

AOR, adjusted odds ratio; CI, confidence interval; ns, non-significant association.